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INTRODUCTION
Breast cancer is the second most common malignancy in 
Korean women, metastasis occurs in 20-30% of these patients 
[1]. The common sites of metastasis of breast cancer are bone, 
lung, liver, and brain, but solitary gastrointestinal metastasis 
from breast cancer is extremely rare [2]. We experienced a case 
of solitary ileal metastasis from breast cancer.
CASE REPORT
A 45-years-old woman presented with melena for several 
weeks. She showed no other abdominal or constitutional symp-
toms. The physical examination revealed mild abdominal dis-
tension with an alert mentality and stable vital signs. The labo-
ratory data was within the normal range. Abdominal radio-
graph showed nonspecific multiple small bowel gases. Colo-
noscopy showed an ulcerative mucosal lesion in the terminal 
ileum (Figure 1), and biopsy was performed. Microscopic ex-
amination showed focal infiltration of neoplastic cells in intes-
tinal wall. In Hematoxylin and Eosin stain, mucosal surface of 
epithelium was intact, but some tumor emboli infiltrations were 
seen in lamina propria, which is the typical feature of metastat-
ic carcinoma (Figure 2A). In immunohistochemistry (IHC), 
the tumor cells were positive for estrogen receptor (ER) (Figure 
2B) and negative for Cdx-2 (Figure 2C), which indicates met-
astatic carcinoma from breast primary. 
The woman had had a previous medical history of bilateral 
breast cancer and she had undergone breast conserving sur-
gery with sentinel lymph node biopsy for both breasts. Both 
breast cancers were invasive ductal carcinoma (Figure 3A) and 
positive for E-cadherin (Figure 3B). The largest tumor was 1.9 
cm at the greatest diameter and both sentinel lymph nodes were 
free of malignancy. The IHC stains for ER and progesterone 
receptor (PR) were positive in most of tumor cells and HER2 
staining was negative. She then received adjuvant hormonal 
therapy with tamoxifen and GnRH agonist (Goserelin, Zola-
dex
®; AstraZeneca, Macclesfiled, UK) on and radiation thera-
py. The postoperative follow-up evaluation was done with breast 
sonography and mammography at 6 months intervals and with 
bone scanning at 1-year intervals. The torso positron emission 
tomography scan was performed at 19 months after surgery 
and mildly increased uptake was detected in the terminal ile-
um (SUV max=5.7) (Figure 4A, B). We considered this origi-
nated from inflammation, and planned short-term follow up.
She was diagnosed with solitary ileal metastasis from breast 
cancer by colonoscopic biopsy at 22 months after surgery. We 
checked her whole bowels by capsule endoscope and could 
not find any other lesions. Retroperitoneal computed tomog-
raphy (CT) showed thickening of the wall of terminal ileum 
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The common sites of metastasis of breast cancer are bone, lung, 
and liver, but gastrointestinal metastasis from breast cancer is 
rare. We experienced a case of solitary ileal metastasis from breast 
cancer. A 45-years-old woman presented with melena for several 
weeks. She showed no other abdominal symptoms. Colonosco-
py findings showed an ulcerative mucosal lesion in the terminal 
ileum, and biopsy was performed. Pathologic examination re-
vealed metastatic carcinoma, originated from breast. The tumor 
cells were positive for estrogen receptor and negative for Cdx-2. 
She had had a previous medical history of bilateral breast cancer 
and undergone breast conserving surgery with sentinel lymph node 
biopsy for both breasts. The torso positron emission tomography 
scan at 19 months after surgery showed mildly increased uptake in 
the terminal ileum which was considered as inflammation. Final-
ly, she was diagnosed with solitary ileal metastasis from breast 
cancer at 22 months after surgery.
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and enlargement of multiple lymph nodes around them (Fig-
ure 4C). She wanted to have an operation in other hospital and 
was transferred. We heard that she underwent hand-assisted 
laparoscopic ileocecectomy, and then received chemotherapy.
DISCUSSION
Small bowel malignancies make up only 1.1-2.4% of all gas-
trointestinal malignancies, and primary adenocarcinoma is the 
most common of all the small bowel malignancies [3]. Most 
small bowel metastases are from primary tumors such as ma-
lignant melanoma, colon cancer and cervical cancer, and me-
tastasis from breast cancer is uncommon [4]. However, autop-
sy of patients with breast cancer revealed 15-16% of metastasis 
was found in gastrointestinal tract and the most common site 
of gastrointestinal metastasis was the stomach followed by the 
large bowel and small bowel [4]. Almost all the signs and symp-
toms of gastrointestinal diseases, including abdominal pain, 
diarrhea, gastrointestinal bleeding, intestinal obstruction, in- Figure 1. Colonoscopy showed ulcerative mucosa (arrow) in the termi-
nal ileum.
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Figure 2. (A) Microscopic findings of terminal ileal wall showed tumor emboli infiltrations (arrows) in lamina propria lymphatic spaces, but intact muco-
sal epithelium (H&E stain, ×100). (B) The tumor cells (arrows) were positive for estrogen receptor; (C) negative for Cdx-2, a critical nuclear transcrip-
tion factor for intestinal development (immunohistochemical staining,×100).
Figure 3. (A) Microscopic findings of both breast revealed infiltration of malignant ductal cells. The primary invasive ductal carcinomas of breast  shows 
well differentiation and no lymphovascular invasions (H&E stain, ×200). (B) The malignant cells are positive for E-cadherin (immunohistochemical stain-
ing,×200).
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tussusceptions and more, can be present in patients with met-
astatic small bowel malignancies [5-7]. This creates problems 
for making the differential diagnosis from other benign gas-
trointestinal diseases. A delayed diagnosis makes the treatment 
of metastatic cancer more difficult. In our case, if further exam-
ination, such as endoscopy, was performed when PET showed 
mild uptake in terminal ileum, more immediately, we may be 
get better result, now. If there are suspicions of breast origin in 
diagnosis, breast specific IHC stains such as ER or PR and in-
testinal specific IHC stains such as Cdx-2 can be helpful.
In our case, primary breast cancer was invasive ductal carci-
noma. But lobular carcinoma rather than ductal carcinoma and 
tumor with PR positivity rather than ER positivity has a pro-
pensity for gastrointestinal metastasis in patients with breast 
cancer [8,9]. The treatment options for small bowel metastasis 
from breast cancer are surgery, chemotherapy, hormonal ther-
apy and radiation therapy depending on the cancer status.
In patients with breast cancer, metastasis to gastrointestinal 
tract is uncommon and its clinical manifestations are non-spe-
cific, which makes it hard to diagnosis correctly in one swoop. 
Yet having a suspicion of gastrointestinal metastasis from breast 
cancer and making an early diagnosis are the most important 
keys for the prognosis of metastatic breast cancer. Although it 
is uncommon for breast cancer to metastasize to the gastroin-
testinal tract, we should always keep in mind the possibility of 
such metastasis in patients with a previous history of breast 
cancer.
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Figure 4. (A) The torso positron emission tomography scan showed mild uptake in the terminal ileum (SUV max=5.7). (B) The retroperitoneal com-
puted tomography showed thickening of the wall of terminal ileum and multiple lymph node enlargement around them.